SEP 30, 2016 11:30 AM PDT

Blood Test Guides Depression Treatments

WRITTEN BY: Xuan Pham
When the mind isn’t doing well, doctors can find clues in the body. In particular, scientists in the UK recently found that people with depression have different inflammation profiles that can be picked up with a simple blood test. In addition to helping to diagnose patients, the team says the inflammation biomarkers can help predict which drugs will be most effective for certain patients. This would, in essence, help reduce the trial and error that often plagues depression patients.

Emerging depression treatments guided by blood test | Image: pixabay.com
 
Depression is one of the most common mental disorders in the US. In 2014, nearly 15.7 million Americans experienced at least one major depressive episode. And because depression often goes undiagnosed, this number could be even higher.
 
Currently, a popular treatment for depression option is with pharmacotherapy – using antidepressants to reduce mood symptoms. There are many classes of antidepressants, each targeting different neurotransmitters associated with depression. Though there are many options for which antidepressants patients can take, getting the right drug for the right patient is a challenge.
 
"If [patients] don't get better, they just switch drugs and then switch again with hope that one will work," said Carmine Pariante, professor at Kings College London and senior author of the study.
 
Researchers have long known that stress influences inflammation markers, and this is no different with depression. To test whether a blood test can reveal these markers, scientists at the King's College London tested blood samples from 140 people with depression.
 
The team honed in on 2 biological markers: MIF (migration inhibitory factor) and IL-1B (interleukin-1beta). They found that about one-third of their cohort have high levels of these 2 markers. Interestingly, these same patients were also less likely to respond to SSRIs (selective serotonin reuptake inhibitors) and tricyclic antidepressants – two of the most common, first-line drugs doctors typically prescribe.
 

"We determined with 100% accuracy when patients will not respond to these first-line drugs," Pariante said. "This one-third need a more complex intervention."

The blood test could theoretically distinguish these patients and doctors can prescribe an alternative antidepressant class from the start. "We would not want to go in prescribing too much medicine if it's not necessary, but we would want to escalate people sooner rather than later if they need it,” said Pariante. This would bypass side-effects from antidepressants that would not appear to be outweighed by any benefits for the patients.
 
"Being able to target those people with depression who don't respond to medication would be one of the most exciting steps forward in the treatment of mental illness for decades,” said Marjorie Wallace from the mental health charity SANE.

Additional sources: CNN, BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 12, 2019
Health & Medicine
NOV 12, 2019
Glue, It's What Keeps A Heart Together
If you’ve ever had a cavity filled at the dentist, you know the steps. First goes in the filling, followed by a wand of UV light to harden the materi...
NOV 12, 2019
Cardiology
NOV 12, 2019
Opioid Addiction Comes With Increased Risk Of Infection
Public health officials have put decades of work into the battle against infectious diseases. Now, this progress is at risk of being dismantled. A recent s...
NOV 12, 2019
Clinical & Molecular DX
NOV 12, 2019
Diagnosing Autism, The Child-Friendly Way
The term autism spectrum disorder ASD is an umbrella term for a wide range of conditions. These conditions are characterized by difficulty in social situat...
NOV 12, 2019
Health & Medicine
NOV 12, 2019
On the bright side, optimists may live longer
Do you see the glass half empty, or half full? If your answer is full, you may be in luck: Optimistic people live 11-15% longer than pessimists, according...
NOV 12, 2019
Neuroscience
NOV 12, 2019
Nanolaser designed to function in brain tissue
Scientists have developed a nanolaser (miniaturized laser) that can function inside living tissues. According to researchers, the laser is about 1/1,000th the thickness of a single human hair...
NOV 12, 2019
Genetics & Genomics
NOV 12, 2019
A 'Molecular Clock' for Determining a Child's Age
This tool can aid in the diagnosis of developmental disorders, including autism spectrum disorder....
Loading Comments...